Sebastian Wehle
Director/Board Member at TIGENIX NV
Sebastian Wehle active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TIGENIX NV | Director/Board Member | 15/06/2018 | - |
Career history of Sebastian Wehle
Former positions of Sebastian Wehle
| Companies | Position | Start | End |
|---|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - | - |
Training of Sebastian Wehle
| University of Kiel | Doctorate Degree |
Statistics
International
| Belgium | 2 |
| Japan | 2 |
| Germany | 2 |
Operational
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
TiGenix NV
 TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
- Stock Market
- Insiders
- Sebastian Wehle
- Experience
